Healthcare - Drug Manufacturers - General - NASDAQ - US
$ 88.4
-4.03 %
$ 110 B
Market Cap
982.22
P/E
Price Target
Average
--4.38%
Revenue Forecast
Estimate
4.07%
EBIT
Estimate
1.26%
Net Income
Estimate
18.67%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Gilead Sciences, Inc.
Wall Street analysts predict an average 1-year price target for GILD of $84.5 , with forecasts ranging from a low of $69 to a high of $105 .
GILD Lowest Price Target
Wall Street Target
69 USD
-21.95%
GILD Average Price Target
Wall Street Target
84.5 USD
-4.38%
GILD Highest Price Target
Wall Street Target
105 USD
18.78%
REVENUE FORECAST
Revenue Forecast Chart GILD
EBIT FORECAST
EBIT Forecast Chart GILD
NET INCOME FORECAST
Net Income Chart GILD